• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电穿孔和脂质纳米颗粒介导的自扩增mRNA在皮肤中递送后的表达动力学和先天免疫反应

Expression Kinetics and Innate Immune Response after Electroporation and LNP-Mediated Delivery of a Self-Amplifying mRNA in the Skin.

作者信息

Huysmans Hanne, Zhong Zifu, De Temmerman Joyca, Mui Barbara L, Tam Ying K, Mc Cafferty Séan, Gitsels Arlieke, Vanrompay Daisy, Sanders Niek N

机构信息

Laboratory of Gene Therapy, Department of Nutrition, Genetics and Ethology, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.

Laboratory of Gene Therapy, Department of Nutrition, Genetics and Ethology, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium; Department of Pathology, Bacteriology and Poultry Diseases, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.

出版信息

Mol Ther Nucleic Acids. 2019 Sep 6;17:867-878. doi: 10.1016/j.omtn.2019.08.001. Epub 2019 Aug 7.

DOI:10.1016/j.omtn.2019.08.001
PMID:31472371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6722285/
Abstract

In this work, we studied the expression kinetics and innate immune response of a self-amplifying mRNA (sa-RNA) after electroporation and lipid-nanoparticle (LNP)-mediated delivery in the skin of mice. Intradermal electroporation of the sa-RNA resulted in a plateau-shaped expression, with the plateau between day 3 and day 10. The overall protein expression of sa-RNA was significantly higher than that obtained after electroporation of plasmid DNA (pDNA) or non-replication mRNAs. Moreover, using IFN-β reporter mice, we elucidated that intradermal electroporation of sa-RNA induced a short-lived moderate innate immune response, which did not affect the expression of the sa-RNA. A completely different expression profile and innate immune response were observed when LNPs were used. The expression peaked 24 h after intradermal injection of sa-RNA-LNPs and subsequently showed a sharp drop. This drop might be explained by a translational blockage caused by the strong innate immune response that we observed in IFN-β reporter mice shortly (4 h) after intradermal injection of sa-RNA-LNPs. A final interesting observation was the capacity of sa-RNA-LNPs to transfect the draining lymph nodes after intradermal injection.

摘要

在本研究中,我们研究了自扩增mRNA(sa-RNA)在小鼠皮肤中经电穿孔和脂质纳米颗粒(LNP)介导递送后的表达动力学和先天免疫反应。sa-RNA的皮内电穿孔导致表达呈平台状,平台期在第3天至第10天之间。sa-RNA的总体蛋白表达显著高于质粒DNA(pDNA)或非复制mRNA电穿孔后获得的表达。此外,使用IFN-β报告基因小鼠,我们阐明了sa-RNA的皮内电穿孔诱导了短暂的中度先天免疫反应,这并不影响sa-RNA的表达。当使用LNP时,观察到了完全不同的表达谱和先天免疫反应。在皮内注射sa-RNA-LNP后24小时表达达到峰值,随后急剧下降。这种下降可能是由于我们在皮内注射sa-RNA-LNP后不久(4小时)在IFN-β报告基因小鼠中观察到的强烈先天免疫反应导致的翻译阻断。最后一个有趣的观察结果是sa-RNA-LNP在皮内注射后转染引流淋巴结的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/23ca54923746/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/522ae5cb24ac/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/b1d9be679a42/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/f38e2feed78c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/f6a0aafe3174/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/dfcbee4c65f2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/233ffa8617a3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/c32c74fb0df6/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/3d238ddf92f1/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/23ca54923746/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/522ae5cb24ac/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/b1d9be679a42/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/f38e2feed78c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/f6a0aafe3174/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/dfcbee4c65f2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/233ffa8617a3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/c32c74fb0df6/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/3d238ddf92f1/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25e/6722285/23ca54923746/gr8.jpg

相似文献

1
Expression Kinetics and Innate Immune Response after Electroporation and LNP-Mediated Delivery of a Self-Amplifying mRNA in the Skin.电穿孔和脂质纳米颗粒介导的自扩增mRNA在皮肤中递送后的表达动力学和先天免疫反应
Mol Ther Nucleic Acids. 2019 Sep 6;17:867-878. doi: 10.1016/j.omtn.2019.08.001. Epub 2019 Aug 7.
2
Comparison of the Expression Kinetics and Immunostimulatory Activity of Replicating mRNA, Nonreplicating mRNA, and pDNA after Intradermal Electroporation in Pigs.经皮电穿孔后猪皮肤内复制型 mRNA、非复制型 mRNA 和 pDNA 的表达动力学和免疫刺激性比较。
Mol Pharm. 2018 Feb 5;15(2):377-384. doi: 10.1021/acs.molpharmaceut.7b00722. Epub 2018 Jan 17.
3
Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines.脂质纳米颗粒的甘露糖基化可提高自我扩增RNA(SAM)疫苗的效力。
ACS Infect Dis. 2019 Sep 13;5(9):1546-1558. doi: 10.1021/acsinfecdis.9b00084. Epub 2019 Jul 23.
4
The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency.纳米颗粒形式和给药途径对自扩增 mRNA 疫苗效力的影响。
J Control Release. 2022 Feb;342:388-399. doi: 10.1016/j.jconrel.2021.12.008. Epub 2021 Dec 10.
5
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.脂质纳米颗粒通过不同途径递送至小鼠体内的核苷修饰mRNA的表达动力学
J Control Release. 2015 Nov 10;217:345-51. doi: 10.1016/j.jconrel.2015.08.007. Epub 2015 Aug 8.
6
Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ.通过原位电穿孔增强自我扩增mRNA疫苗的递送和效力。
Vaccines (Basel). 2013 Aug 22;1(3):367-83. doi: 10.3390/vaccines1030367.
7
Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs.皮质甾类药物和纤维素纯化分别提高了 sa-mRNA 的体内翻译和疫苗效力。
Mol Ther. 2021 Apr 7;29(4):1370-1381. doi: 10.1016/j.ymthe.2021.01.023. Epub 2021 Jan 21.
8
Conjugation of Mannans to Enhance the Potency of Liposome Nanoparticles for the Delivery of RNA Vaccines.甘露聚糖的缀合以增强脂质体纳米颗粒用于递送RNA疫苗的效力。
Pharmaceutics. 2021 Feb 9;13(2):240. doi: 10.3390/pharmaceutics13020240.
9
Probing delivery of a lipid nanoparticle encapsulated self-amplifying mRNA vaccine using coherent Raman microscopy and multiphoton imaging.采用相干拉曼显微镜和多光子成像技术探测包裹在脂质纳米颗粒中的自扩增 mRNA 疫苗的递呈。
Sci Rep. 2024 Feb 22;14(1):4348. doi: 10.1038/s41598-024-54697-3.
10
Improving the Repeatability and Efficacy of Intradermal Electroporated Self-Replicating mRNA.提高皮内电穿孔自我复制信使核糖核酸的重复性和疗效。
Mol Ther Nucleic Acids. 2019 Sep 6;17:388-395. doi: 10.1016/j.omtn.2019.06.011. Epub 2019 Jun 28.

引用本文的文献

1
Unleashing the potential of mRNA: Overcoming delivery challenges with nanoparticles.释放信使核糖核酸的潜力:利用纳米颗粒克服递送挑战。
Bioeng Transl Med. 2024 Aug 15;10(2):e10713. doi: 10.1002/btm2.10713. eCollection 2025 Mar.
2
Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics.用于靶向递送的脂质纳米颗粒的组成:在mRNA治疗中的应用。
Front Pharmacol. 2024 Oct 23;15:1466337. doi: 10.3389/fphar.2024.1466337. eCollection 2024.
3
Advanced technologies for the development of infectious disease vaccines.

本文引用的文献

1
Improving the Repeatability and Efficacy of Intradermal Electroporated Self-Replicating mRNA.提高皮内电穿孔自我复制信使核糖核酸的重复性和疗效。
Mol Ther Nucleic Acids. 2019 Sep 6;17:388-395. doi: 10.1016/j.omtn.2019.06.011. Epub 2019 Jun 28.
2
Nanoscale platforms for messenger RNA delivery.用于信使 RNA 递送的纳米级平台。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Mar;11(2):e1530. doi: 10.1002/wnan.1530. Epub 2018 May 4.
3
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility.脂质纳米颗粒助力基因治疗:从理念到临床应用。
传染病疫苗开发的先进技术。
Nat Rev Drug Discov. 2024 Dec;23(12):914-938. doi: 10.1038/s41573-024-01041-z. Epub 2024 Oct 21.
4
Realizing time-staggered expression of nucleic acid-encoded proteins by co-delivery of messenger RNA and plasmid DNA on a single nanocarrier.通过在单个纳米载体上共同递送信使核糖核酸和质粒脱氧核糖核酸实现核酸编码蛋白质的时间交错表达。
Drug Deliv Transl Res. 2024 Dec;14(12):3339-3353. doi: 10.1007/s13346-024-01668-w. Epub 2024 Jul 15.
5
Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency.自我扩增RNA中经修饰核苷酸的完全取代可抑制干扰素反应并提高效力。
Nat Biotechnol. 2025 May;43(5):720-726. doi: 10.1038/s41587-024-02306-z. Epub 2024 Jul 8.
6
Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery .用于器官选择性核酸递送的优化脂质纳米颗粒(LNPs)
iScience. 2024 Apr 23;27(6):109804. doi: 10.1016/j.isci.2024.109804. eCollection 2024 Jun 21.
7
Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19.自我扩增RNA:抗新冠病毒mRNA疫苗的第二次革命
Vaccines (Basel). 2024 Mar 17;12(3):318. doi: 10.3390/vaccines12030318.
8
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity.脂质纳米颗粒(LNP)递送载体辅助的肿瘤免疫靶向控释mRNA疫苗
Vaccines (Basel). 2024 Feb 12;12(2):186. doi: 10.3390/vaccines12020186.
9
Strategies to reduce the risks of mRNA drug and vaccine toxicity.降低 mRNA 药物和疫苗毒性风险的策略。
Nat Rev Drug Discov. 2024 Apr;23(4):281-300. doi: 10.1038/s41573-023-00859-3. Epub 2024 Jan 23.
10
Development of novel SARS-CoV-2 viral vectors.新型 SARS-CoV-2 病毒载体的开发。
Sci Rep. 2023 Aug 11;13(1):13053. doi: 10.1038/s41598-023-40370-8.
Nucleic Acid Ther. 2018 Jun;28(3):146-157. doi: 10.1089/nat.2018.0721. Epub 2018 Apr 23.
4
The Regulation of Translation in Alphavirus-Infected Cells.甲病毒感染细胞中的翻译调控。
Viruses. 2018 Feb 8;10(2):70. doi: 10.3390/v10020070.
5
mRNA vaccines - a new era in vaccinology.mRNA 疫苗——疫苗学的新纪元。
Nat Rev Drug Discov. 2018 Apr;17(4):261-279. doi: 10.1038/nrd.2017.243. Epub 2018 Jan 12.
6
Comparison of the Expression Kinetics and Immunostimulatory Activity of Replicating mRNA, Nonreplicating mRNA, and pDNA after Intradermal Electroporation in Pigs.经皮电穿孔后猪皮肤内复制型 mRNA、非复制型 mRNA 和 pDNA 的表达动力学和免疫刺激性比较。
Mol Pharm. 2018 Feb 5;15(2):377-384. doi: 10.1021/acs.molpharmaceut.7b00722. Epub 2018 Jan 17.
7
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial.一种信使 RNA 狂犬病疫苗在健康成年人中的安全性和免疫原性:一项开放标签、非随机、前瞻性、首次人体 1 期临床试验。
Lancet. 2017 Sep 23;390(10101):1511-1520. doi: 10.1016/S0140-6736(17)31665-3. Epub 2017 Jul 25.
8
Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design.自我扩增RNA疫苗诱导IFN介导的抗病毒反应:对疫苗设计的启示
J Immunol. 2017 May 15;198(10):4012-4024. doi: 10.4049/jimmunol.1601877. Epub 2017 Apr 17.
9
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge.核苷修饰 mRNA 编码的广泛中和抗体的给药可保护人源化小鼠免受 HIV-1 挑战。
Nat Commun. 2017 Mar 2;8:14630. doi: 10.1038/ncomms14630.
10
Systemic delivery of factor IX messenger RNA for protein replacement therapy.用于蛋白质替代疗法的IX因子信使核糖核酸的全身递送
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):E1941-E1950. doi: 10.1073/pnas.1619653114. Epub 2017 Feb 15.